MIGUEL ANGEL
MARCHENA FERNANDEZ
Investigador en el periodo 2015-2023
Universidad de Alcalá
Alcalá de Henares, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Alcalá (4)
2022
-
Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa
Cell Death and Disease, Vol. 13, Núm. 4
2018
-
Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa
Molecular Neurodegeneration, Vol. 13, Núm. 1
-
Removal of the blue component of light significantly decreases retinal damage after high intensity exposure
PLoS ONE, Vol. 13, Núm. 3
2016
-
Intravitreal injection of proinsulin-loaded microspheres delays photoreceptor cell death and vision loss in the rd10 mouse model of retinitis pigmentosa
Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 8, pp. 3610-3618